Sellimonas intestinalis

BacteriaBacillotaClostridiaLachnospiralesLachnospiraceaeSellimonas
MCA-BAC-000011
TaxID: 1653434 | Rank: species
Biology & Ecology
Biology
Gram Statusgram-positive
Oxygen Toleranceobligate anaerobe
Morphologybacillus (rod)
Ecology
Primary Nichesgut
Reservoirhuman
Metabolites

No metabolite relationships documented for this taxon.

Clinical Profile
Pathobiont
yes no context dependent unknown
Clinical Rolescommensal
Typical Specimenstool
Bloom Triggers antibiotic exposure
Risk Contextspost-antibiotic
Clinical Associations:
E3
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Sellimonas intestinalis relative abundance was significantly higher in individuals with prior exposure to clindamycin, fluoroquinolones, or flucloxacillin, with disruptions persisting for 4–8 years post-prescription, in a multi-cohort observational study of 14,979 Swedish adults (SCAPIS, SIMPLER, MOS cohorts).
PMID: 41814006
D016638 Critical Illness D003428 Cross Infection
E3
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Higher Sellimonas intestinalis relative abundance was positively associated with elevated BMI, waist-hip ratio, serum triglycerides, and C-reactive protein in the SCAPIS cohort (n≈10,456), consistent with a cardiometabolic risk profile.
PMID: 41814006
H01742 Coronary artery disease H01637 Hypertriglyceridemia
Last reviewed: 2026-04-01
Related Taxa Shared Niche = same body site   Shared Risk = same vulnerable population